IRadimed

IRadimed Interest Coverage

The Interest Coverage Ratio of IRadimed (IRMD) as of Oct 10, 2026 is 13.00. In the previous year, Interest Coverage Ratio was 10.21 — a change of 27.29% (higher).

Interest Coverage

13.00

YoY

27.29%

Last updated:

Interest Coverage Ratio of IRadimed is 2025 13.00 . Interest Coverage Ratio of IRadimed was 2024 10.21 . It decreases by 27.29% higher compared to the previous year.

The IRadimed Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
31.60 USD
Jan 1, 2019
21.62 USD
Jan 1, 2020
-5.40 USD
Jan 1, 2021
490.88 USD
Jan 1, 2022
28.41 USD
Jan 1, 2023
11.68 USD
Jan 1, 2024
10.21 USD
Jan 1, 2025
13.00 USD
The IRadimed Interest Coverage history
YEARInterest CoverageYoY
13.00+27.29%
10.21-12.55%
11.68-58.89%
28.41-94.21%
490.88-9,189.35%
-5.40-124.98%
21.62-31.58%
31.60+170.49%
11.68-98.93%
1,092.01+89.70%
575.66+1,026.57%
51.10—
Access this data via the Eulerpool API

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

Interest Coverage Ratio of IRadimed is 13.00 in 2025.

Interest Coverage Ratio of IRadimed changed from 10.21 to 13.00, representing a 27.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio IRadimed since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's IRadimed with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — IRadimed

All Key Metrics — IRadimed